Physician profile
Mark Allen Jordan
NPI 1568801025
$8,273.23
in general payments reported to CMS, 2019-2025
8 companies · $1,979 in 2025
The $1,979 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,081 · 2020: $2,067 · 2021: $112 · 2024: $33.97 · 2025: $1,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,455 · Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,455.09 |
| Food and Beverage | $558.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,538.74 | 2019-2020 | |
| Stryker Corporation | $2,432.00 | 2019-2025 | Mako, Aequalis, Insignia |
| Great Lakes Orthopedics | $1,339.85 | 2019-2020 | |
| Smith+Nephew, INC. | $707.28 | 2019 | |
| Zimmer Biomet Holdings, INC. | $191.39 | 2019-2020 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Depuy Synthes Sales INC. | $18.98 | 2024 | Monovisc, Orthovisc |
| True North Surgical INC | $14.99 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.